Patents by Inventor Nicolas Wolff

Nicolas Wolff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200365932
    Abstract: A battery module comprises at least one battery cell and a cell mount, whereby the battery cell has a cylindrical cell housing with an external lateral surface, whereby an external thread is created in the lateral surface, and whereby the cell mount has at least one threaded hole with an internal thread into which the at least one battery cell is screwed in or can be screwed in.
    Type: Application
    Filed: May 18, 2020
    Publication date: November 19, 2020
    Applicant: VOLKSWAGEN AKTIENGESELLSCHAFT
    Inventors: Bastian SCHAAR, Nicolas WOLFF
  • Patent number: 10227653
    Abstract: The invention relates to polypeptides containing a cytoplasmic domain ending with a MAST-2 binding domain, from 11 to 13 residues, the first two residues of which are S and W, and the last four residues of which are Q, T, R and L, the polypeptides presenting a high affinity for the PDZ domain of the human MAST2 protein. The invention also relates to polynucleotides, vectors, lentiviral particles, cells as well as compositions containing the same. The invention is also directed to the use of the polypeptides, polynucleotides, vectors, lentiviral particles, cells and compositions in the treatment and/or prevention of a disease, disorder or condition, which alters the Central Nervous System (CNS) and/or the Peripheral Nervous System (PNS). The invention also concerns molecular signatures of cellular genes to determine the neurosurvival and/or neuroprotection activity of a molecule.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: March 12, 2019
    Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Christophe Prehaud, Monique Lafon, Nicolas Wolff, Zakir Khan, Elouan Terrien, Sandrine Vitry
  • Publication number: 20170022567
    Abstract: The invention relates to polypeptides containing a cytoplasmic domain ending with a MAST-2 binding domain, from 11 to 13 residues, the first two residues of which are S and W, and the last four residues of which are Q, T, R and L, the polypeptides presenting a high affinity for the PDZ domain of the human MAST2 protein. The invention also relates to polynucleotides, vectors, lentiviral particles, cells as well as compositions containing the same. The invention is also directed to the use of the polypeptides, polynucleotides, vectors, lentiviral particles, cells and compositions in the treatment and/or prevention of a disease, disorder or condition, which alters the Central Nervous System (CNS) and/or the Peripheral Nervous System (PNS). The invention also concerns molecular signatures of cellular genes to determine the neurosurvival and/or neuroprotection activity of a molecule.
    Type: Application
    Filed: September 14, 2016
    Publication date: January 26, 2017
    Inventors: Christophe Prehaud, Monique Lafon, Nicolas Wolff, Zakir Khan, Elouan Terrien, Sandrine Vitry
  • Patent number: 9475851
    Abstract: The invention relates to polypeptides containing a cytoplasmic domain ending with a MAST-2 binding domain, from 11 to 13 residues, the first two residues of which are S and W, and the last four residues of which are Q, T, R and L, the polypeptides presenting a high affinity for the PDZ domain of the human MAST2 protein. The invention also relates to polynucleotides, vectors, lentiviral particles, cells as well as compositions containing the same. The invention is also directed to the use of the polypeptides, polynucleotides, vectors, lentiviral particles, cells and compositions in the treatment and/or prevention of a disease, disorder or condition, which alters the Central Nervous System (CNS) and/or the Peripheral Nervous System (PNS). The invention also concerns molecular signatures of cellular genes to determine the neurosurvival and/or neuroprotection activity of a molecule.
    Type: Grant
    Filed: November 7, 2012
    Date of Patent: October 25, 2016
    Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PIERRE ET MARIE CURIE
    Inventors: Christophe Prehaud, Monique Lafon, Nicolas Wolff, Zakir Khan, Elouan Terrien, Sandrine Vitry
  • Patent number: 9234005
    Abstract: The application provides products, which may trigger pro-apoptotic or pro-death effects on neoplastic cells and/or tissues of the human nervous system, more particularly on neoplastic cells and/or tissues of the human CNS. The products of the application can be used as anti-proliferative or tumoricid agents in the treatment and/or palliation and/or prevention of neoplasms of the human nervous system, more particularly of glioblastoma or brain stem glioma. Therefore, the application also relates to compositions, such as pharmaceutical compositions or drugs, which comprise at least one of said products, as well as to the biotechnological and medical applications of said products and compositions.
    Type: Grant
    Filed: October 11, 2012
    Date of Patent: January 12, 2016
    Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PIERRE ET MARIE CURIE PARIS
    Inventors: Nicolas Wolff, Monique Lafon, Nicolas Babault
  • Publication number: 20140315822
    Abstract: The invention relates to polypeptides containing a cytoplasmic domain ending with a MAST-2 binding domain, from 11 to 13 residues, the first two residues of which are S and W, and the last four residues of which are Q, T, R and L, said polypeptides presenting a high affinity for the PDZ domain of the human MAST2 protein. The invention also relates to polynucleotides, vectors, lentiviral particles, cells as well as compositions comprising the same. The invention is also directed to the use of said polypeptides, polynucleotides, vectors, lentiviral particles, cells and compositions in the treatment and/or prevention of a disease, disorder or condition, which alters the Central Nervous System (CNS) and/or the Peripheral Nervous System (PNS). The invention also concerns molecular signatures of cellular genes to determine the neurosurvival and/or neuroprotection activity of a molecule.
    Type: Application
    Filed: November 7, 2012
    Publication date: October 23, 2014
    Applicant: CENTRE NATIONAL DE LA RECHERCE SCIENTIFIQUE
    Inventors: Christophe Prehaud, Monique Lafon, Nicolas Wolff, Zakir Khan, Elouan Terrien, Sandrine Vitry
  • Publication number: 20100227526
    Abstract: A system for animating decorative elements or products moved by means of strings connecting the decorative elements to an animating mechanism includes a closed animating device (2) in which the animating mechanism is arranged and enclosed, decorative elements or products (4) animated by animating strings (5), the decorative elements (4) and their animating strings (5) being arranged outside the animating device (2) and distributed in a space to be decorated, control wires (6) being provided to connect the animating strings (5) of the decorative elements (4) to the animating mechanism, and elements (7) for transmitting movements to the decorative elements (4). The transmitting elements are distributed in the space to be decorated depending on the location of the decorative elements (4) relative to the animating device (2).
    Type: Application
    Filed: January 22, 2007
    Publication date: September 9, 2010
    Applicant: Adjl"Atelier Des Jum"s
    Inventors: Nicolas Wolff, Bastien Wolff
  • Publication number: 20090181614
    Abstract: The present invention comprises a computer-implemented method for providing audio content to mobile devices via a simple, efficient telephony-based system that delivers on-demand playback to a mobile device. The present invention dynamically allocates separate and unique direct inward dialing (DID) numbers to unique combinations of identifiable user-specific mobile devices and specific pieces of audio content such that a user receives a uniquely allocated DID number at the mobile device that links to a specific piece of stored audio content. Calling a DID number enables playback of the associated specific piece of stored audio content to an identifiable user-specific mobile device. A user may call the DID number conveniently at any time and hear playback of the stored audio content without having to first select from a series menu to identify and initiate playback of the piece of stored audio content.
    Type: Application
    Filed: January 15, 2008
    Publication date: July 16, 2009
    Inventors: Nicolas Wolff, Erik Schwartz